Histone H3 K27M mutations in adult cerebellar high-grade gliomas

Adams H, Chaichana KL, Avendaño J, Liu B, Raza SM, Quiñones-Hinojosa A (2013) Adult cerebellar glioblastoma: understanding survival and prognostic factors using a population-based database from 1973 to 2009. World Neurosurg 80:e237–e243 Utsuki S, Oka H, Miyajima Y, Kijima C, Yasui Y, Fujii K (2012) Adult cerebellar glioblastoma cases have different characteristics from supratentorial glioblastoma. Brain Tumor Pathol 29:87–95 Jeswani S, Nuño M, Folkerts V, Mukherjee D, Black KL, Patil CG (2013) Comparison of survival between cerebellar and supratentorial glioblastoma patients: surveillance, epidemiology, and end results (SEER) analysis. Neurosurgery 73:240–246 Sturm D, Witt H, Hovestadt V et al (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22:425–437 Hawkins CE, Ellison DW, Sturm D (2016) Diffuse midline glioma, H3 K27M-mutant. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Ellison DW (eds) WHO classification of tumors of the central nervous system. IARC Press, Lyon, pp 57–59 Fontebasso AM, Schwartzentruber J, Khuong-Quang DA et al (2013) Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas. Acta Neuropathol 125:659–669 Fontebasso AM, Papillon-Cavanagh S, Schwartzentruber J et al (2014) Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma. Nat Genet 46:462–466 Venneti S, Santi M, Felicella MM et al (2014) A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas. Acta Neuropathol 128:743–753 Solomon DA, Wood MD, Tihan T et al (2016) Diffuse midline gliomas with histone H3-K27M mutation: a series of 47 cases assessing the spectrum of morphologic variation and associated genetic alterations. Brain Pathol 26:569–580 Meyronet D, Esteban-Mader M, Bonnet C et al (2017) Characteristics of H3 K27M-mutant gliomas in adults. Neuro Oncol. doi:10.1093/neuonc/now274 Gessi M, Gielen GH, Dreschmann V, Waha A, Pietsch T (2015) High frequency of H3F3A K27M mutations characterizes pediatric and adult high-grade gliomas of the spinal cord. Acta Neuropathol 130:435–437 Aihara K, Mukasa A, Gotoh K et al (2014) H3F3A K27M mutations in thalamic gliomas from young adult patients. Neuro Oncol 16:140–146 Feng J, Hao S, Pan C et al (2015) The H33 K27M mutation results in a poorer prognosis in brainstem gliomas than thalamic gliomas in adults. Hum Pathol 46:1626–1632 Joyon N, Tauziède-Espariat A, Alentorn A et al (2017) K27M mutation in H3F3A in ganglioglioma grade I with spontaneous malignant transformation extends the histopathological spectrum of the histone H3 oncogenic pathway. Neuropathol Appl Neurobiol 43:271–276 Vettermann FJ, Neumann JE, Suchorska B et al (2016) K27M midline gliomas display malignant progression by imaging and histology. Neuropathol Appl Neurobiol. doi:10.1111/nan12371 Schwartzentruber J, Korshunov A, Liu XY et al (2012) Driver mutations in histone H33 and chromatin remodelling genes in paediatric glioblastoma. Nature 482:226–231 Karremann M, Rausche U, Roth D et al (2013) Cerebellar location may predict an unfavourable prognosis in paediatric high-grade glioma. Br J Cancer 109:844–851 Nguyen AT, Colin C, Nanni-Metellus I et al (2015) Evidence for BRAF V600E and H3F3A K27M double mutations in paediatric glial and glioneuronal tumors. Neuropathol Appl Neurobiol 41:403–408 Reuss DE, Kratz A, Sahm F et al (2015) Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities. Acta Neuropathol 130:407–417 Castel D, Philippe C, Calmon R et al (2015) Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathol 130:815–827 Chan AK, Mao Y, Ng HK (2016) TP53 and histone H33 mutations in triple-negative lower-grade gliomas. N Engl J Med 375:2206–2208 Liu B, Arakawa Y, Murata D et al (2016) Clinicopathological, radiological, and genetic analyses of cerebellar gangliogliomas with long-term survival. World Neurosurg 94:521–528 Pagès M, Beccaria K, Boddaert N et al (2016) Co-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma. Brain Pathol. doi:10.1111/bpa12473 Nagaishi M, Nobusawa S, Yokoo H et al (2016) Genetic mutations in high grade gliomas of the adult spinal cord. Brain Tumor Pathol 33:267–269 Reyes-Botero G, Giry M, Mokhtari K et al (2014) Molecular analysis of diffuse intrinsic brainstem gliomas in adults. J Neurooncol 116:405–411 Nakazato Y, Ishizeki J, Takahashi K, Yamaguchi H, Kamei T, Mori T (1982) Localization of S-100 protein and glial fibrillary acidic protein-related antigen in pleomorphic adenoma of the salivary glands. Lab Invest 46:621–626 Ikemura M, Shibahara J, Mukasa A et al (2016) Utility of ATRX immunohistochemistry in diagnosis of adult diffuse gliomas. Histopathology 69:260–267 Poussaint TY, Kocak M, Vajapeyam S et al (2011) MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC). Neuro Oncol 13:417–427 Gessi M, Capper D, Sahm F et al (2016) Evidence of H3 K27M mutations in posterior fossa ependymomas. Acta Neuropathol 132:635–637 Hashizume R, Andor N, Ihara Y et al (2014) Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma. Nat Med 20:1394–1396 Grasso CS, Tang Y, Truffaux N et al (2015) Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nat Med 21:555–559 Trial of panobinostat in children with diffuse intrinsic pontine glioma (PBTC-047). https://clinicaltrials.gov/ct2/show/NCT02717455. Accessed 5 April 2017 Hennika T, Hu G, Olaciregui NG et al (2017) Pre-clinical study of panobinostat in xenograft and genetically engineered murine diffuse intrinsic pontine glioma models. PLoS One 12:e0169485